Conversely, we previously demonstrated that EphA2 inhibition could attenuate the malignant cellular behavior of RCC cells in vitro [8], similar to previous in vitro results against cellular migration and invasion in non-small-cell lung cancer [14]. The gene discussed is EPHA2; the disease is renal cell carcinoma.